Correlation Between Viatris and TC BioPharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viatris and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viatris and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viatris and TC BioPharm plc, you can compare the effects of market volatilities on Viatris and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viatris with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viatris and TC BioPharm.

Diversification Opportunities for Viatris and TC BioPharm

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between Viatris and TCBPW is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Viatris and TC BioPharm plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm plc and Viatris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viatris are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm plc has no effect on the direction of Viatris i.e., Viatris and TC BioPharm go up and down completely randomly.

Pair Corralation between Viatris and TC BioPharm

Given the investment horizon of 90 days Viatris is expected to generate 5.63 times less return on investment than TC BioPharm. But when comparing it to its historical volatility, Viatris is 8.34 times less risky than TC BioPharm. It trades about 0.17 of its potential returns per unit of risk. TC BioPharm plc is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  1.49  in TC BioPharm plc on August 31, 2024 and sell it today you would earn a total of  0.01  from holding TC BioPharm plc or generate 0.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Viatris  vs.  TC BioPharm plc

 Performance 
       Timeline  
Viatris 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Viatris are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Viatris may actually be approaching a critical reversion point that can send shares even higher in December 2024.
TC BioPharm plc 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in TC BioPharm plc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, TC BioPharm showed solid returns over the last few months and may actually be approaching a breakup point.

Viatris and TC BioPharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viatris and TC BioPharm

The main advantage of trading using opposite Viatris and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viatris position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.
The idea behind Viatris and TC BioPharm plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals